Max Totrov

Title: Max Totrov: Innovator in Cancer Treatment and Drug Design

Introduction

Max Totrov is a prominent inventor based in San Diego, CA, known for his significant contributions to the fields of cancer treatment and drug design. With a total of 2 patents, he has made strides in developing innovative solutions aimed at improving patient outcomes in oncology.

Latest Patents

Max Totrov's latest patents include groundbreaking work in the treatment of cancer. His first patent provides compositions of matter, kits, and methods for treating cancer by inhibiting a poly-ADP-ribose polymerase. This invention outlines formulations and methods for administering these compositions effectively to patients. His second patent focuses on drug design for tubulin inhibitors. This invention describes a computer-assisted method for designing a tubulin inhibitor, detailing the steps involved in determining interactions between tubulin proteins and candidate inhibitors, ultimately leading to effective treatments for diseases associated with tubulin.

Career Highlights

Max Totrov is currently associated with Bipar Sciences, Inc., where he continues to push the boundaries of medical research and innovation. His work is characterized by a commitment to developing effective therapeutic strategies that address critical health challenges.

Collaborations

Max collaborates with notable colleagues, including Valeria S Ossovskaya and John P Burnier, who contribute to his research endeavors and help advance the projects he undertakes.

Conclusion

Max Totrov's innovative work in cancer treatment and drug design exemplifies the impact of dedicated inventors in the medical field. His patents reflect a commitment to improving healthcare through scientific advancement.